Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • COVID-19 Prevention
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • IgAN
      • IgAN & C3G
      • Renal Transplant Maintenance
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+ HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
      • Wet AMD
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • COPD
      • Interstitial Lung Disease
    • Rheumatology
      • BACK
      • Rheumatology
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
    • Urology
      • BACK
      • Urology
      • Uncomplicated Urinary Tract Infections
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

clinical topic updates

MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibition in Chronic Lymphocytic Leukemia
Oncology

MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibition in Chronic Lymphocytic Leukemia

clinical topic updates
By Jennifer R. Brown, MD, PhD
Potential Usefulness of Dual B-Cell Receptor and PARP Inhibition in Relapsed del(11q) Chronic Lymphocytic Leukemia
Oncology

Potential Usefulness of Dual B-Cell Receptor and PARP Inhibition in Relapsed del(11q) Chronic Lymphocytic Leukemia

clinical topic updates
By Jennifer R. Brown, MD, PhD
Optimal Use of Imaging in Rheumatoid Arthritis
Rheumatology

Optimal Use of Imaging in Rheumatoid Arthritis

clinical topic updates
By Eric M. Ruderman, MD
Radiographic Progression From Factors Other Than High Disease Activity in the Current Treat-to-Target Paradigm
Rheumatology

Radiographic Progression From Factors Other Than High Disease Activity in the Current Treat-to-Target Paradigm

clinical topic updates
By Eric M. Ruderman, MD
Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells
Oncology

Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells

clinical topic updates
By Julie M. Vose, MD, MBA, FASCO
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?